Chemoinformaics analysis of 2,3,4,6-TETRAMETHYL-D-Glucose
| Molecular Weight | 236.264 | nRot | 5 |
| Heavy Atom Molecular Weight | 216.104 | nRig | 6 |
| Exact Molecular Weight | 236.126 | nRing | 1 |
| Solubility: LogS | 0.525 | nHRing | 1 |
| Solubility: LogP | -0.586 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 34.8479 |
| nHD | 1 | BPOL | 28.7441 |
| QED | 0.687 |
| Synth | 3.951 |
| Natural Product Likeliness | 1.532 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.509 |
| HIA | 0.365 |
| CACO-2 | -4.916 |
| MDCK | 0.0000795 |
| BBB | 0.309 |
| PPB | 0.112414 |
| VDSS | 0.711 |
| FU | 0.792357 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.807 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.671 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.01 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.196 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.28 |
| CL | 2.576 |
| T12 | 0.264 |
| hERG | 0.057 |
| Ames | 0.352 |
| ROA | 0.107 |
| SkinSen | 0.185 |
| Carcinogencity | 0.042 |
| EI | 0.03 |
| Respiratory | 0.023 |
| NR-Aromatase | 0.049 |
| Antiviral | No |
| Prediction | 0.834186 |